Alexios Matikas, Xingrong Liu, Balazs Acs, Johan Hartman, Theodoros Foukakis, Antonios Valachis. "A nationwide population-based study on the incidence and prognosis of patients with HER2+ breast cancer eligible for adjuvant pertuzumab in the modern era of neoadjuvant therapy.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.e12508